Table 4.
Comparison of Survivor and Nonsurvivor Extracorporeal Membrane Oxygenation (ECMO) Features
| Variable | Survivors | Nonsurvivors | p Value |
|---|---|---|---|
| Duration of ECMO before surgery, days, median (range) | 3 (0–7) | 6 (0–19) | 0.22 |
| Mode of ECMO | 0.33 | ||
| Venoarterial | 15 | 9 | |
| Venovenous and combination | 1 | 1 | |
| Prime solution | 0.67 | ||
| Plasmalyte | 7 | 6 | |
| Blood | 9 | 4 | |
| Cannulation site | 0.63 | ||
| Thoracic cannulation | 2 | 2 | |
| Peripheral cannulation | 14 | 8 | |
| Total ECMO duration, days, median (range) | 4 (0–14) | 8 (2–27) | 0.02 |
| ECMO complications | 0.121 | ||
| At least one complication | 11 | 10 | |
| No Complications | 5 | 0 | |
| Central nervous system injury | 4 | 6 | 0.11 |
| Renal injury | 1 | 2 | 0.54 |
| Nosocomial infection | 4 | 3 | 1.0 |
| Bleeding requiring transfusion | 3 | 4 | 0.40 |